Dror Ortho-Design, Inc.
DROR
Other OTC0.01
USD
- -
- -
CIK
0001282980
ISIN
US6700851099
CUSIP
670085109
Return %
Stock
S&P500
1Y
-37.37
17.85
3Y
-60.33
64.56
5Y
-90.08
69.89
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Eliyahu Haddad
- Full Time Employees
- 4
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Shatner Street 3 Jerusalem JM Israel 34387
- IPO Date
- Jun 8, 2006
- CIK
- 0001282980
- Website
- zsmile.com
- Similar Companies
- Business
- Dror Ortho-Design, Inc. engages in the development and commercialization of AI-assisted orthodontic technologies and removable orthodontic devices. The company’s main products and services include the Aerodentis smart aligner platform (comprising the Aerodentis smartphone application, the Aerodentis AI Cloud for analytics and treatment planning, and the smart aligner system with a base control unit and IoT components); ZSmile, an AI-powered cloud ecosystem for patient data capture, treatment analytics, and digital workflow management; and related orthodontic devices designed to move teeth toward ideal occlusion using pulsating air generated by the embedded micro-balloon mechanism. Aerodentis and ZSmile are marketed to orthodontists, dentists, and patients as an end-to-end digital solution that aims to reduce chair time, attract new patients, and improve treatment efficiency. The company is headquartered in Jerusalem, Israel, and operates primarily in the United States market and other international regions through strategic partnerships and distribution arrangements. Dror Ortho-Design, Inc. was founded in 1999 and originally operated under a different corporate name before adopting its current designation. The company’s operations focus on research and development, product design, regulatory-compliant manufacturing partnerships, and commercialization of its AI-enabled orthodontic platform for various patient demographics, including children and adults. The business model emphasizes integration with clinical workflows, digital patient engagement, and data-driven treatment management to support orthodontic professionals and care providers. Foundationally, the company positions Aerodentis as a replacement paradigm for traditional braces, aiming to shorten treatment timelines and broaden market reach through innovative, patient-centric alignment solutions. The corporate structure includes potential subsidiary or partner relationships aligned with its technology platform and manufacturing collaborations to support scalable production and global distribution.
Dror Ortho-Design Receives 510(k) FDA Clearance for Next-Generation Smile Correction Solution
Dror Ortho-Design Launches Global ZSmile Innovation Network Initiative to Transform the Stagnating Aligner Market
Dror Successfully Completes User Experience Trial of its new ZSmile Platform
Dror Ortho-Design Posts Updated CEO Investor Presentation
Dror Ortho-Design Introduces ZSmile: A Revolution in Eco-Friendly Orthodontics
Dror Ortho-Design, Inc. Launches New ZSMILE Product Brand
Dror Ortho-Design, Inc. Files Three New Patents for its AI Based Smile Correction Solution
Dror Ortho-Design, Inc. Announces New Ticker Symbol “DROR”